Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.
about
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infectionCholera toxin: a paradigm of a multifunctional proteinRole of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targetingProtein crystallography and infectious diseases.Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal deliveryGeneration of female genital tract antibody responses by local or central (common) mucosal immunizationSystemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxinImmune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugatesEffectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunizationRecombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.Protection of gerbils from amebic liver abscess by vaccination with a 25-mer peptide derived from the cysteine-rich region of Entamoeba histolytica galactose-specific adherence lectinAnti-class II monoclonal antibody-targeted Vibrio cholerae TcpA pilin: modulation of serologic response, epitope specificity, and isotypeOral microbial ecology and the role of salivary immunoglobulin AStructure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines.Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvantsCharacterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxinsMucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2/B chimera induces antigen-specific Th2-type responses in mice.Progress towards development of a vaccine for amebiasis.Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in ratsLocal and systemic antibody responses to dextran-cholera toxin B subunit conjugatesSalivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccineDevelopment of antibody-secreting cells and antigen-specific T cells in cervical lymph nodes after intranasal immunizationOral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin
P2860
Q24548763-E3E4FAA5-DC17-4273-9CF5-A172ADF1F489Q24598726-7937E30A-AD4A-4777-9373-82B80804ABA1Q24676979-84B9CEBB-BC49-4D46-A875-AA6BE246CB2CQ30419162-3F02F2EA-37A9-4EF3-B3DF-3B704DF9046AQ33584872-38E22A9F-BB00-4DE8-B111-6E2F0198652FQ33591251-777324B7-88AA-4C00-ABE2-4DC001913B77Q33592158-F49AE5CC-3794-4E81-B9CB-4AFBCD349F03Q33596220-E037E953-B6B0-48A9-925A-7C2578393A2EQ33597587-8F53C4CD-812A-48B1-A3E9-AEA020E965A5Q33611155-754F7517-1F8A-4CF9-BF40-BF265BC9C0B1Q33743411-B376E912-0510-4B08-BAEF-E2522F4ACDC9Q33749997-C0C7BBBE-F1A5-47B5-8BB4-E981104A034EQ33750130-F2A1DD8F-3E97-470C-8928-10A05A3E65AFQ33762159-DC303E76-17CB-4EA1-B0DA-40AD9866D7E9Q33999182-49511DC1-A067-4E99-A7C5-9A41DBE711DAQ34005585-00E0781D-B40E-4CE4-9B05-B432591AB469Q34007541-123CBAD6-40A3-4897-BC3C-59049A08BB67Q34009811-67D7115D-0366-4996-8C2D-80C97B80695EQ34009973-93F7D2D9-6FFE-4CDE-8087-164046CBA2CEQ34128200-DFADEED8-3E02-4C6B-8BE2-8AD8010D3FAFQ34520511-8949361B-1C8E-45DF-AC40-749BF0FD12AFQ34522325-0B99332A-6DC1-491F-9CD5-944E25FEC473Q34522757-CC7D4CD8-E1B8-468D-ADA4-4A184F2E9504Q34532411-0223C289-9869-4156-96BE-F092F05D6592Q34639828-2319495B-78BF-4946-AD87-574CEB1D7823Q34972133-48AB33B4-4B52-44DE-AE4C-D92EFC94B5EAQ35191220-07A9B80D-97CB-4A43-8AE8-1EB8B0693EE5Q35375735-172864EB-E440-4F2D-A5B0-0E88CB0088FFQ35400277-6DCEC48C-A41F-4818-88EC-AAFBAC0F65ECQ35413101-96A09763-F11F-4841-B179-58B2CA46E8BEQ35413377-AA1526FD-8B84-4EE1-845C-36B3C0D5E9DDQ35482140-7FA021F7-0A59-4F79-9043-53A64AF63077Q35490149-DE5581FD-6A4A-4BDA-8B47-DB039CB8D728Q35520692-92FA6A7F-A764-44BE-B6E6-58B752B6B2D9Q35533881-B86CC4E3-9656-470D-9BA4-15379B61EBBEQ35543988-479086DF-4641-4671-8230-34FCB135B7FAQ35545804-0B88FD21-2A55-417B-8B35-7AA823F8C7AEQ35546011-B0D570C5-A98F-400E-BECD-0E897F661BF6Q35550710-3D683ED5-39CF-47C5-96C9-19432404C4FFQ35559595-8F1E0D57-0269-47F1-821D-F5319A687992
P2860
Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues.
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Oral administration of a strep ...... ands and extramucosal tissues.
@ast
Oral administration of a strep ...... ands and extramucosal tissues.
@en
type
label
Oral administration of a strep ...... ands and extramucosal tissues.
@ast
Oral administration of a strep ...... ands and extramucosal tissues.
@en
prefLabel
Oral administration of a strep ...... ands and extramucosal tissues.
@ast
Oral administration of a strep ...... ands and extramucosal tissues.
@en
P2093
P2860
P1476
Oral administration of a strep ...... ands and extramucosal tissues.
@en
P2093
C Czerkinsky
M Lindblad
M W Russell
P2860
P304
P407
P577
1989-04-01T00:00:00Z